Max Robotics — Global Service Robot Directory + US Certification

About

Zhihong Xu is a leading orthopedic surgeon and researcher advancing the frontier of robotic-assisted joint replacement surgery. His primary research focuses on the clinical application and validation of robotic systems for total hip arthroplasty (THA), particularly the MAKO and LANCET platforms. Xu’s major contributions include pioneering the practical implementation of robotic-arm assisted THA in China, detailing the pre-operative planning and surgical procedures that enable individualized, precise arthroplasty. His work has been instrumental in demonstrating the superiority of robotic assistance over conventional techniques. In a landmark 2024 multicenter randomized controlled trial, Xu and his team proved that the LANCET robotic system significantly improves surgical efficiency and accuracy, with 116 patients showing enhanced outcomes. With his most-cited paper accumulating 16 citations and his recent trial already garnering 9, Xu’s impact is rapidly growing. He is a key figure in translating cutting-edge robotics from engineering labs to operating rooms, making complex surgeries safer and more reproducible. His achievements position him as a pioneer in China’s adoption of smart orthopedics, directly shaping the future of precision joint replacement.